199 related articles for article (PubMed ID: 38019415)
1. Mendelian Randomization Identifies Genetically Supported Drug Targets for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Zhu Y; Li M; Wang H; Yang F; Du R; Pang X; Bai J; Huang X
Mol Neurobiol; 2023 Nov; ():. PubMed ID: 38019415
[TBL] [Abstract][Full Text] [Related]
2. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro.
Duan QQ; Wang H; Su WM; Gu XJ; Shen XF; Jiang Z; Ren YL; Cao B; Li GB; Wang Y; Chen YP
BMC Med; 2024 Mar; 22(1):96. PubMed ID: 38443977
[TBL] [Abstract][Full Text] [Related]
3. Assessing Causal Relationship Between Human Blood Metabolites and Five Neurodegenerative Diseases With GWAS Summary Statistics.
Chen H; Qiao J; Wang T; Shao Z; Huang S; Zeng P
Front Neurosci; 2021; 15():680104. PubMed ID: 34955704
[No Abstract] [Full Text] [Related]
4. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
[TBL] [Abstract][Full Text] [Related]
5. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis.
Diekstra FP; Van Deerlin VM; van Swieten JC; Al-Chalabi A; Ludolph AC; Weishaupt JH; Hardiman O; Landers JE; Brown RH; van Es MA; Pasterkamp RJ; Koppers M; Andersen PM; Estrada K; Rivadeneira F; Hofman A; Uitterlinden AG; van Damme P; Melki J; Meininger V; Shatunov A; Shaw CE; Leigh PN; Shaw PJ; Morrison KE; Fogh I; Chiò A; Traynor BJ; Czell D; Weber M; Heutink P; de Bakker PI; Silani V; Robberecht W; van den Berg LH; Veldink JH
Ann Neurol; 2014 Jul; 76(1):120-33. PubMed ID: 24931836
[TBL] [Abstract][Full Text] [Related]
6. Targeting ER-Mitochondria Signaling as a Therapeutic Target for Frontotemporal Dementia and Related Amyotrophic Lateral Sclerosis.
Martín-Guerrero SM; Markovinovic A; Mórotz GM; Salam S; Noble W; Miller CCJ
Front Cell Dev Biol; 2022; 10():915931. PubMed ID: 35693938
[TBL] [Abstract][Full Text] [Related]
7. Tale of two diseases: amyotrophic lateral sclerosis and frontotemporal dementia.
Verma A
Neurol India; 2014; 62(4):347-51. PubMed ID: 25237937
[TBL] [Abstract][Full Text] [Related]
8. TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts.
Le Ber I; De Septenville A; Millecamps S; Camuzat A; Caroppo P; Couratier P; Blanc F; Lacomblez L; Sellal F; Fleury MC; Meininger V; Cazeneuve C; Clot F; Flabeau O; LeGuern E; Brice A;
Neurobiol Aging; 2015 Nov; 36(11):3116.e5-3116.e8. PubMed ID: 26476236
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal imaging in
Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
[TBL] [Abstract][Full Text] [Related]
10. The converging roles of sequestosome-1/p62 in the molecular pathways of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
Davidson JM; Chung RS; Lee A
Neurobiol Dis; 2022 May; 166():105653. PubMed ID: 35143965
[TBL] [Abstract][Full Text] [Related]
11. Association between TBK1 mutations and risk of amyotrophic lateral sclerosis/frontotemporal dementia spectrum: a meta-analysis.
Cui R; Tuo M; Li P; Zhou C
Neurol Sci; 2018 May; 39(5):811-820. PubMed ID: 29349657
[TBL] [Abstract][Full Text] [Related]
12. Delineating the relationship between amyotrophic lateral sclerosis and frontotemporal dementia: Sequence and structure-based predictions.
Kumar V; Islam A; Hassan MI; Ahmad F
Biochim Biophys Acta; 2016 Sep; 1862(9):1742-54. PubMed ID: 27318084
[TBL] [Abstract][Full Text] [Related]
13. Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS.
Taskesen E; Mishra A; van der Sluis S; Ferrari R; ; Veldink JH; van Es MA; Smit AB; Posthuma D; Pijnenburg Y
Sci Rep; 2017 Aug; 7(1):8899. PubMed ID: 28827549
[TBL] [Abstract][Full Text] [Related]
14. Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with
Barschke P; Oeckl P; Steinacker P; Al Shweiki MR; Weishaupt JH; Landwehrmeyer GB; Anderl-Straub S; Weydt P; Diehl-Schmid J; Danek A; Kornhuber J; Schroeter ML; Prudlo J; Jahn H; Fassbender K; Lauer M; van der Ende EL; van Swieten JC; Volk AE; Ludolph AC; Otto M;
J Neurol Neurosurg Psychiatry; 2020 May; 91(5):503-511. PubMed ID: 32132225
[TBL] [Abstract][Full Text] [Related]
15. Mutation spectrum of chinese amyotrophic lateral sclerosis patients with frontotemporal dementia.
Yang X; Sun X; Liu Q; Liu L; Li J; Cai Z; Zhang K; Liu S; He D; Shen D; Liu M; Cui L; Zhang X
Orphanet J Rare Dis; 2022 Nov; 17(1):404. PubMed ID: 36345033
[TBL] [Abstract][Full Text] [Related]
16. Causal effects of serum sex hormone binding protein levels on the risk of amyotrophic lateral sclerosis: a mendelian randomization study.
Ou YN; Yang L; Wu BS; Tan L; Yu JT
Ann Transl Med; 2022 Oct; 10(19):1054. PubMed ID: 36330403
[TBL] [Abstract][Full Text] [Related]
17. SQSTM1 variant in disorders of the frontotemporal dementia-amyotrophic lateral sclerosis spectrum: identification of a novel heterozygous variant and a review of the literature.
Li W; Gao H; Dong X; Zheng D
J Neurol; 2021 Apr; 268(4):1351-1357. PubMed ID: 33125541
[TBL] [Abstract][Full Text] [Related]
18. CSF angiogenin levels in amyotrophic lateral Sclerosis-Frontotemporal dementia spectrum.
Morelli C; Tiloca C; Colombrita C; Zambon A; Soranna D; Lafronza A; Solca F; Carelli L; Poletti B; Doretti A; Verde F; Maderna L; Ticozzi N; Ratti A; Silani V
Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):63-69. PubMed ID: 31852251
[No Abstract] [Full Text] [Related]
19. Involvement of the caudate nucleus head and its networks in sporadic amyotrophic lateral sclerosis-frontotemporal dementia continuum.
Masuda M; Senda J; Watanabe H; Epifanio B; Tanaka Y; Imai K; Riku Y; Li Y; Nakamura R; Ito M; Ishigaki S; Atsuta N; Koike H; Katsuno M; Hattori N; Naganawa S; Sobue G
Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):571-579. PubMed ID: 27684890
[TBL] [Abstract][Full Text] [Related]
20. Schizotypal traits across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum: pathomechanistic insights.
Tse NY; Tu S; Chen Y; Caga J; Dobson-Stone C; Kwok JB; Halliday GM; Ahmed RM; Hodges JR; Piguet O; Kiernan MC; Devenney EM
J Neurol; 2022 Aug; 269(8):4241-4252. PubMed ID: 35279757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
